213 related articles for article (PubMed ID: 32335272)
1. miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis.
Loffreda A; Nizzardo M; Arosio A; Ruepp MD; Calogero RA; Volinia S; Galasso M; Bendotti C; Ferrarese C; Lunetta C; Rizzuti M; Ronchi AE; Mühlemann O; Tremolizzo L; Corti S; Barabino SML
Prog Neurobiol; 2020 Jul; 190():101803. PubMed ID: 32335272
[TBL] [Abstract][Full Text] [Related]
2. Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients.
Kim KY; Kim YR; Choi KW; Lee M; Lee S; Im W; Shin JY; Kim JY; Hong YH; Kim M; Kim JI; Sung JJ
Transl Neurodegener; 2020 Jul; 9(1):23. PubMed ID: 32605607
[TBL] [Abstract][Full Text] [Related]
3. SOD1
Marton S; Miquel E; Acosta-Rodríguez J; Fontenla S; Libisch G; Cassina P
ASN Neuro; 2023; 15():17590914231197527. PubMed ID: 37644868
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.
Marcuzzo S; Bonanno S; Kapetis D; Barzago C; Cavalcante P; D'Alessandro S; Mantegazza R; Bernasconi P
Mol Brain; 2015 Jan; 8():5. PubMed ID: 25626686
[TBL] [Abstract][Full Text] [Related]
5. Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9.
Zhou F; Zhang C; Guan Y; Chen Y; Lu Q; Jie L; Gao H; Du H; Zhang H; Liu Y; Wang X
J Neurochem; 2018 Apr; 145(1):51-67. PubMed ID: 28960306
[TBL] [Abstract][Full Text] [Related]
6. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
Butovsky O; Jedrychowski MP; Cialic R; Krasemann S; Murugaiyan G; Fanek Z; Greco DJ; Wu PM; Doykan CE; Kiner O; Lawson RJ; Frosch MP; Pochet N; Fatimy RE; Krichevsky AM; Gygi SP; Lassmann H; Berry J; Cudkowicz ME; Weiner HL
Ann Neurol; 2015 Jan; 77(1):75-99. PubMed ID: 25381879
[TBL] [Abstract][Full Text] [Related]
7. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice.
Koval ED; Shaner C; Zhang P; du Maine X; Fischer K; Tay J; Chau BN; Wu GF; Miller TM
Hum Mol Genet; 2013 Oct; 22(20):4127-35. PubMed ID: 23740943
[TBL] [Abstract][Full Text] [Related]
8. HuD regulates SOD1 expression during oxidative stress in differentiated neuroblastoma cells and sporadic ALS motor cortex.
Dell'Orco M; Sardone V; Gardiner AS; Pansarasa O; Bordoni M; Perrone-Bizzozero NI; Cereda C
Neurobiol Dis; 2021 Jan; 148():105211. PubMed ID: 33271327
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of microRNA-29a in ALS mice: functional analysis of its inhibition.
Nolan K; Mitchem MR; Jimenez-Mateos EM; Henshall DC; Concannon CG; Prehn JH
J Mol Neurosci; 2014 Jun; 53(2):231-41. PubMed ID: 24696165
[TBL] [Abstract][Full Text] [Related]
10. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.
Cunha C; Santos C; Gomes C; Fernandes A; Correia AM; Sebastião AM; Vaz AR; Brites D
Mol Neurobiol; 2018 May; 55(5):4207-4224. PubMed ID: 28612258
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
Kim HC; Zhang Y; King PH; Lu L
J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
[TBL] [Abstract][Full Text] [Related]
12. miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non-Cell-Autonomous Mechanism in ALS.
Maimon R; Ionescu A; Bonnie A; Sweetat S; Wald-Altman S; Inbar S; Gradus T; Trotti D; Weil M; Behar O; Perlson E
J Neurosci; 2018 Jun; 38(24):5478-5494. PubMed ID: 29773756
[TBL] [Abstract][Full Text] [Related]
13. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-183-5p is stress-inducible and protects neurons against cell death in amyotrophic lateral sclerosis.
Li C; Chen Y; Chen X; Wei Q; Ou R; Gu X; Cao B; Shang H
J Cell Mol Med; 2020 Aug; 24(15):8614-8622. PubMed ID: 32558113
[TBL] [Abstract][Full Text] [Related]
15. MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker.
Giagnorio E; Malacarne C; Cavalcante P; Scandiffio L; Cattaneo M; Pensato V; Gellera C; Riva N; Quattrini A; Dalla Bella E; Lauria G; Mantegazza R; Bonanno S; Marcuzzo S
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902041
[TBL] [Abstract][Full Text] [Related]
16. Silencing strategies for therapy of SOD1-mediated ALS.
van Zundert B; Brown RH
Neurosci Lett; 2017 Jan; 636():32-39. PubMed ID: 27507699
[TBL] [Abstract][Full Text] [Related]
17. PAK4 suppresses motor neuron degeneration in hSOD1
Cong C; Liang W; Zhang C; Wang Y; Yang Y; Wang X; Wang S; Huo D; Wang H; Wang D; Feng H
Cell Prolif; 2021 Apr; 54(4):e13003. PubMed ID: 33615605
[TBL] [Abstract][Full Text] [Related]
18. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
Rinchetti P; Rizzuti M; Faravelli I; Corti S
Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
[TBL] [Abstract][Full Text] [Related]
20. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.
Varcianna A; Myszczynska MA; Castelli LM; O'Neill B; Kim Y; Talbot J; Nyberg S; Nyamali I; Heath PR; Stopford MJ; Hautbergue GM; Ferraiuolo L
EBioMedicine; 2019 Feb; 40():626-635. PubMed ID: 30711519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
